Literature DB >> 24333305

Plasma-derived medicinal products in Italy: information sources and flows.

Monica Lanzoni1, Claudia Biffoli2, Fabio Candura3, Gabriele Calizzani3, Stefania Vaglio4, Giuliano Grazzini3.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24333305      PMCID: PMC3853980          DOI: 10.2450/2013.004s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  1 in total

Review 1.  The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.

Authors:  Gabriele Calizzani; Stefania Vaglio; Fabio Candura; Samantha Profili; Monica Lanzoni; Karen Cristiano; Maria Rita Tamburrini; Giuliano Grazzini; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

  1 in total
  13 in total

Review 1.  The demand for polyvalent immunoglobulins in Italy.

Authors:  Fabio Candura; Monica Lanzoni; Gabriele Calizzani; Samantha Profili; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Authors:  Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Liviana Catalano; Rosa Chianese; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 3.  Public expenditure for plasma-derived and recombinant medicinal products in Italy.

Authors:  Monica Lanzoni; Fabio Candura; Gabriele Calizzani; Claudia Biffoli; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 4.  Clinical use and the Italian demand for antithrombin.

Authors:  Giancarlo M Liumbruno; Massimo Franchini; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Liviana Catalano; Giuseppina Facco; Simonetta Pupella; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 5.  Clinical use and the Italian demand for prothrombin complex concentrates.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Giuseppina Facco; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 6.  The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.

Authors:  Gabriele Calizzani; Stefania Vaglio; Fabio Candura; Samantha Profili; Monica Lanzoni; Karen Cristiano; Maria Rita Tamburrini; Giuliano Grazzini; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 7.  The demand for factor VIII and for factor IX and the toll fractionation product surplus management.

Authors:  Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Giancarlo M Liumbruno; Massimo Franchini; Pier Mannuccio Mannucci; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 8.  Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.

Authors:  Antonio Coppola; Annarita Tagliaferri; Gabriele Calizzani; Fabio Candura; Massimo Franchini; Carlo Ruosi; Giuliano Grazzini; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 9.  The demand for human albumin in Italy.

Authors:  Stefania Vaglio; Gabriele Calizzani; Monica Lanzoni; Fabio Candura; Samantha Profili; Liviana Catalano; Livia Cannata; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

10.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.